Study Summary
This trial will test a new drug, IMM01-STEM, to see if it is safe and tolerated in people with knee osteoarthritis-related muscle atrophy.
- Muscle Wasting
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: Day 28
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
3 Treatment Groups
Cohort A
1 of 3
Cohort B
1 of 3
Cohort C
1 of 3
Active Control
18 Total Participants · 3 Treatment Groups
Primary Treatment: Cohort A · No Placebo Group · Phase 1 & 2
Trial Logistics
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 50 - 75 · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
To whom does the criteria for this research apply?
"This clinical trial seeks 18 individuals aged between 50 and 75 who suffer from arthrosis. Prerequisites include being able to independently walk more than 50 feet, having a BMI below 40kg/m2, no pre-existing HIV or HBsAg or HCV infections, males agreeing to use contraception for 3 months post treatment, WOCBP must adhere with the protocol's contraceptive instructions during treatment and after last dose of study medication; female participants need negative pregnancy test at screening before receiving IMP; signing informed consent form that includes compliance with all requirements in it; 6 months steroid abstinence prior to Screening Visit; Kellgren-Lawrence grade" - Anonymous Online Contributor
Is the enrollment period for this clinical trial still open?
"The information posted on clinicaltrials.gov indicates that this medical research is recruiting participants at present. The trial was initially published on September 13th 2022 and the most recent update occurred four days later, on September 16th." - Anonymous Online Contributor
What is the upper limit of individuals involved in this investigation?
"Affirmative. The trial details, initially posted on September 13th 2022 and recently updated on the 16th of that same month, are available to view online via clinicaltrials.gov--and state that 18 participants are currently needed between two separate sites." - Anonymous Online Contributor
Are participants in this trial limited to those under sixty years of age?
"This study welcomes those aged between 50 and 75." - Anonymous Online Contributor